What is the name of the domestic drug ibrutinib?
Ibrutinib (lbrutinib) The domestic name is ibrutinib capsules.
Ibrutinib (Ibrutinib) is a targeted treatment for specific types of leukemia and lymphoma. It has made a significant breakthrough in the field of oncology.
Ibrutinib belongs to a class of drugs calledBTKinhibitors. Its main function is to specifically prevent the growth and division of abnormal B cells by inhibiting the activity of BTK enzyme in B lymphocytes. Under normal circumstances, Blymphocytes play an important role in the immune system, but in some leukemias and lymphomas, Blymphocytes can proliferate uncontrollably. The targeting effect of ibrutinib can selectively interfere with this process and reduce the number of malignant B lymphocytes.

Ibrutinib has been approved to treat multiple leukemia and lymphoma types, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and mucosa-associated lymphoid tissue lymphoma (MALTlymphoma). It is often used in patients who have previously received other treatments but failed to achieve adequate relief.
The treatment plan for ibrutinib is usually individualized, and doctors will choose the most appropriate dose and regimen based on the patient's specific condition, disease characteristics, and treatment history. This individualized approach helps maximize the effectiveness of treatment and reduce side effects.
Ibrutinib is currently on the market in China and is included in medical insurance. The domestic price ranges from 10,000 to 20,000. Due to different medical insurance policies in different places, the price is also different. For specific reimbursement information, please consult the local hospital pharmacy or medical insurance bureau. The cheaper types of ibrutinib abroad are generic drugs, mainly Indian generic drugs, Bangladeshi generic drugs and Laos generic drugs, with prices ranging from a few hundred to several thousand yuan. And the ingredients of generic ibrutinib drugs are basically the same as those of domestic ibrutinib drugs.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)